Updated data from a trial of Johnson & Johnson’s experimental “pretzel” showed that more than 80% of bladder ...
A group of Democratic and Republican senators introduced a bill on Thursday that calls for $275 million toward federal ...
The Federal Trade Commission has extended its antitrust review of Novo Holdings’ $16.5 billion purchase of Catalent by potentially another 30 days as it requests additional information. Both the ...
The Senate Finance Committee released a bipartisan draft legislation on Friday morning that would give Medicare bonuses to healthcare providers that help fight generic drug shortages. “It is ...
AstraZeneca is working on moving its BTK inhibitor Calquence into earlier stages of mantle cell lymphoma, releasing what it ...
Moderna’s shift to a more “restrained” posture was on full display Thursday morning during its first-quarter earnings update.
Welcome to Endpoints News’ manufacturing briefs, where we bring you essential news on new builds, collaborations, recalls and ...
Bristol Myers Squibb will give back a preclinical cancer drug to Schrödinger, returning the SOS1 inhibitor that was part of a ...
Jang-Ho Cha had no interest in leaving his post at Novartis, where he led translational medicine for the pharma giant’s work ...
MPM BioImpact and Novo Holdings are among a group of investors pouring $103 million into a psychedelic biotech that MPM took ...
Sarepta Therapeutics’ chief scientist suggested that the FDA was ahead of schedule in reviewing the company’s application to ...
Chroma Medicine laid off an undisclosed number of employees earlier this week, as the privately held startup focuses its ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback